Global Specialty Pharma Group
We are a pharmaceutical group of generic companies.
We are headquartered in Belgium with offices in Ireland and the US.
We Make Affordable Medicines Available To All
We develop value-added generic pharmaceuticals so that patients can continue their treatment.
At the same time, we are reducing costs to the healthcare system for a more sustainable world.
A.forall in numbers
3
Locations: headquarters in Belgium with offices in Ireland and the US
35+
Molecules marketed in Europe and the US, developing mainly injectable generics and value added products covering various therapeutic areas
250+
Distribution and licensing deals signed with leading pharma companies around the world
100%
Committed to a more sustainable future
Our History
2006
It all started then:
The creation of Pharmacy Sales
2007
Start of development of injectable generics
2009
First commercial sales by Pharmacy Sales
2010
Creation of Alter Pharma through consolidation of several entities
2012
Opening Irish logistics operations
2016
Opening US subsidiary
2017
Riverside stepping in
2020
First generic launched in the US
2022
First aquisition
2023
We are now A.forall, uniting all our brands and businesses.
2025
A.forall chooses to focus fully on Generics.
Our Businesses
Our Generics Business
Developing mainly injectable generics and value-added products (new dosages, ready-to-use products etc.).
A portfolio of >35 molecules marketed in Europe and the US and 250+ distribution and licensing deals signed with leading pharma companies.
We focus fully on Generics
As of 29 September 2025, the Pharmacy House is no longer part of the A.forall Group. For more information, please read:
A.forall is taking two important steps towards the future – A.forall
The Pharmacy House divestment — your questions answered – A.forall
#MakingAffordable MedicinesAvailableToAll
Our Company today
Join the team
Our group is the result of our expertise, agility, and flexibility to bridge the gaps in the pharmaceutical industry. If you share our ambition and want to spur innovation and quality throughout the value chain, you are our next partner.